Health Catalyst Management
Management criteria checks 3/4
Health Catalyst's CEO is Dan Burton, appointed in Oct 2012, has a tenure of 12.08 years. directly owns 1.42% of the company’s shares, worth $6.62M. The average tenure of the management team and the board of directors is 2.2 years and 7.5 years respectively.
Key information
Dan Burton
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.1yrs |
| CEO ownership | 1.4% |
| Management average tenure | 2.2yrs |
| Board average tenure | 7.5yrs |
Recent management updates
Recent updates
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
Sep 24Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business
Jul 17
Health Catalyst: Stellar Earnings Growth Projected
Jun 26Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price
Apr 04Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Mar 09Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)
Feb 16Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You
Dec 24Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?
Dec 15Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
Jul 31Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Dec 06Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Nov 03Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
Oct 14Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer
Sep 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$79m |
| Jun 30 2024 | n/a | n/a | -US$86m |
| Mar 31 2024 | n/a | n/a | -US$106m |
| Dec 31 2023 | n/a | n/a | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$124m |
| Jun 30 2023 | n/a | n/a | -US$147m |
| Mar 31 2023 | n/a | n/a | -US$148m |
| Dec 31 2022 | US$4m | US$150k | -US$137m |
| Sep 30 2022 | n/a | n/a | -US$151m |
| Jun 30 2022 | n/a | n/a | -US$145m |
| Mar 31 2022 | n/a | n/a | -US$147m |
| Dec 31 2021 | US$6m | US$300k | -US$153m |
| Sep 30 2021 | n/a | n/a | -US$147m |
| Jun 30 2021 | n/a | n/a | -US$135m |
| Mar 31 2021 | n/a | n/a | -US$126m |
| Dec 31 2020 | US$5m | US$315k | -US$115m |
| Sep 30 2020 | n/a | n/a | -US$86m |
| Jun 30 2020 | n/a | n/a | -US$99m |
| Mar 31 2020 | n/a | n/a | -US$181m |
| Dec 31 2019 | US$4m | US$350k | -US$241m |
| Sep 30 2019 | n/a | n/a | -US$304m |
| Jun 30 2019 | n/a | n/a | -US$282m |
| Mar 31 2019 | n/a | n/a | -US$190m |
| Dec 31 2018 | US$5m | US$315k | -US$114m |
Compensation vs Market: Insufficient data to establish whether Dan's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.
CEO
Dan Burton (49 yo)
12.1yrs
Tenure
Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has strategy and leaders...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 12.1yrs | no data | 1.42% $ 6.6m | |
| Chief Financial Officer | less than a year | US$823.62k | 0.19% $ 874.1k | |
| General Counsel & Secretary of the Board | 1.5yrs | US$946.31k | 0.17% $ 773.2k | |
| Chief People Officer | 6.8yrs | US$1.06m | 0.026% $ 122.8k | |
| Chief Operating Officer | less than a year | no data | 0.051% $ 239.4k | |
| Chief Technology Officer | 2.2yrs | no data | no data | |
| Senior Vice President of Investor Relations and Financial Planning & Analysis | 3.8yrs | no data | no data | |
| Senior Vice President of Marketing & Communications | less than a year | no data | no data | |
| Chief Strategy Officer & Senior VP of Corporate Development | no data | no data | no data | |
| Senior Vice President of International | 5.5yrs | no data | no data | |
| Senior VP & Chief Clinical Officer | no data | no data | no data | |
| Chief Client Success Officer | no data | no data | no data |
2.2yrs
Average Tenure
46yo
Average Age
Experienced Management: HCAT's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 13.2yrs | no data | 1.42% $ 6.6m | |
| Independent Chairman | 8.8yrs | US$316.16k | 0.18% $ 844.0k | |
| Independent Director | 4.8yrs | US$233.49k | 0.076% $ 355.3k | |
| Independent Director | 4.8yrs | US$237.25k | 0.073% $ 342.1k | |
| Independent Director | 8.6yrs | US$244.77k | 0.058% $ 271.9k | |
| Independent Director | 7.5yrs | US$244.77k | 0.092% $ 430.0k | |
| Independent Director | 1.3yrs | no data | no data |
7.5yrs
Average Tenure
60yo
Average Age
Experienced Board: HCAT's board of directors are considered experienced (7.5 years average tenure).